Differential Diagnosis and Work-Up for Elevated RBC Count with Macrocytosis and Thrombocytopenia
This constellation of findings—elevated RBC count, high MCV, high MCH, and low platelets—should immediately raise suspicion for a primary bone marrow disorder, particularly myelodysplastic syndrome (MDS) or a myeloproliferative neoplasm, and requires urgent peripheral blood smear review and hematology consultation.
Initial Critical Assessment
The combination of macrocytosis with thrombocytopenia is particularly concerning and differs from isolated macrocytic anemia. Begin with immediate peripheral blood smear review to assess for dysplastic features, blast cells, and abnormal cell morphology 1. The presence of multiple cytopenias alongside macrocytosis significantly increases the likelihood of a clonal bone marrow disorder 1.
Key Differential Diagnoses
Primary Bone Marrow Disorders (Most Critical)
Myelodysplastic Syndrome (MDS): The most important diagnosis to exclude given the combination of macrocytosis and thrombocytopenia 1. MDS commonly presents with macrocytic anemia (often >100 fL) and thrombocytopenia, particularly in elderly patients 1, 2.
Myeloproliferative Neoplasms: Consider polycythemia vera or essential thrombocythemia variants, though thrombocytopenia makes classic presentations less likely 1.
Aplastic Anemia: Can present with macrocytosis and pancytopenia, though typically RBC count is reduced rather than elevated 3.
Megaloblastic Causes
Vitamin B12 Deficiency: Classic cause of macrocytosis, but typically presents with anemia (reduced RBC count), not elevated RBC count 1.
Folate Deficiency: Similar presentation to B12 deficiency with macrocytosis but usually with anemia 1.
Non-Megaloblastic Causes
Alcoholism: Common cause of macrocytosis (36.5% in one series), but typically doesn't cause thrombocytopenia unless accompanied by liver disease 2, 4.
Medications: Hydroxyurea, azathioprine, and other chemotherapeutic agents can cause macrocytosis and cytopenias 1.
Liver Disease: Can cause macrocytosis and thrombocytopenia through multiple mechanisms including hypersplenism 2, 5.
Hypothyroidism: Causes macrocytosis but rarely affects platelet counts significantly 2, 5.
Algorithmic Work-Up Approach
Step 1: Immediate Laboratory Assessment
Minimum essential workup 1:
- Complete blood count with differential and RBC indices (MCV, MCH, RDW)
- Reticulocyte count (corrected for degree of anemia)
- Peripheral blood smear review for dysplasia, hypersegmented neutrophils, macro-ovalocytes, and blast cells
- Vitamin B12 and folate levels
- Serum ferritin and transferrin saturation
- Liver function tests (AST, ALT, bilirubin, albumin)
- Thyroid-stimulating hormone (TSH)
- Lactate dehydrogenase (LDH) and haptoglobin (to assess for hemolysis)
Step 2: Reticulocyte Count Interpretation
The reticulocyte index is critical for determining the mechanism 1:
Low or normal reticulocyte index (<2.0): Indicates decreased RBC production, suggesting bone marrow dysfunction (MDS, aplastic anemia), vitamin deficiencies, or drug effects 1.
Elevated reticulocyte index (>2.0): Suggests hemolysis or blood loss with compensatory production, though this would be unusual with thrombocytopenia 1.
Step 3: Peripheral Smear Findings
Critical morphologic features to identify 1:
Dysplastic features: Hypersegmented neutrophils (>5 lobes), pseudo-Pelger-Huët anomaly, abnormal megakaryocytes suggest MDS or megaloblastic anemia 1.
Macro-ovalocytes: Characteristic of megaloblastic anemia (B12/folate deficiency) 4.
Blast cells: Any blasts in peripheral blood mandate urgent bone marrow evaluation 1.
High RDW: Indicates heterogeneous RBC population, common in iron deficiency but also seen in MDS and megaloblastic states 1.
Step 4: Bone Marrow Evaluation (When Indicated)
Bone marrow aspiration and biopsy with cytogenetics are mandatory if 1:
- Dysplastic features on peripheral smear
- Unexplained persistent cytopenias
- Blast cells present
- Diagnosis remains unclear after initial workup
Bone marrow examination should include 1:
- Aspirate for morphology and blast count
- Trephine biopsy for cellularity and architecture
- Cytogenetic analysis (karyotype)
- Flow cytometry if available
- Next-generation sequencing for clonal markers in difficult cases
Step 5: Specific Diagnostic Criteria
For MDS diagnosis 1:
- Persistent cytopenias (>4 months)
- Dysplasia in ≥10% of cells in one or more lineages
- Blast count <20% in blood and marrow
- Exclusion of other causes (B12/folate deficiency, medications, toxins)
For megaloblastic anemia 1:
- Vitamin B12 <200 pg/mL or folate <2 ng/mL
- Macrocytosis with hypersegmented neutrophils
- Elevated homocysteine and/or methylmalonic acid if B12 borderline
Critical Pitfalls to Avoid
Do not assume isolated vitamin deficiency explains thrombocytopenia: While B12/folate deficiency can cause pancytopenia, the combination with elevated RBC count is atypical and warrants bone marrow evaluation 1.
Do not delay hematology referral: The presence of thrombocytopenia with macrocytosis requires specialist evaluation, particularly if dysplasia is suspected 2.
Recognize that macrocytosis can occur without anemia: 20.9% of B12-deficient patients present with isolated macrocytosis, but elevated RBC count is unusual 4.
Consider medication history carefully: Chemotherapy agents, immunosuppressants, and anticonvulsants commonly cause macrocytosis and cytopenias 1.
Exclude pseudothrombocytopenia: Always verify low platelet count with peripheral smear to exclude EDTA-dependent platelet clumping 6.
When to Refer to Hematology
Immediate hematology consultation is indicated when 1, 2:
- Any dysplastic features on peripheral smear
- Unexplained combination of macrocytosis and thrombocytopenia
- Blast cells present
- Multiple cytopenias persist after correction of nutritional deficiencies
- Diagnosis remains unclear after comprehensive workup
The elevated RBC count in this scenario is particularly unusual and suggests either a primary marrow disorder with clonal proliferation or a compensatory mechanism that requires expert interpretation.